Baker Bros. Advisors LP 13D and 13G filings for TScan Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-23 4:25 pm Purchase | 2024-04-19 | 13D | TScan Therapeutics, Inc. TCRX | Baker Bros. Advisors LP | 2,828,938 6.100% | 35,000 (+1.25%) | Filing |
| 2023-06-02 4:06 pm Purchase | 2023-05-25 | 13D | TScan Therapeutics, Inc. TCRX | Baker Bros. Advisors LP | 2,793,938 6.500% | 9,146 (+0.33%) | Filing |
| 2022-05-12 4:45 pm Purchase | 2022-05-10 | 13D | TScan Therapeutics, Inc. TCRX | Baker Bros. Advisors LP | 2,784,792 14.700% | 1,359,792 (+95.42%) | Filing |
| 2021-07-22 4:20 pm Purchase | 2021-07-20 | 13D | TScan Therapeutics, Inc. TCRX | Baker Bros. Advisors LP | 1,425,000 7.600% | 1,425,000 (New Position) | Filing |